PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
27-Feb-2026 Global Pharmaceutical Drug Delivery Market Expected to Reach USD 3.405 Trillion by 2035 Vantage Market Research
27-Feb-2026 Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights ACCESS Newswire
27-Feb-2026 Year-End Report 2025 ACCESS Newswire
26-Feb-2026 BioNxt Announces Closing of Shares for Debt Settlement ACCESS Newswire
26-Feb-2026 Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025 ACCESS Newswire
26-Feb-2026 NHI Announces The First Quarter 2026 Dividend ACCESS Newswire
26-Feb-2026 NHI Issues Investor Update ACCESS Newswire
26-Feb-2026 Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025 ACCESS Newswire
26-Feb-2026 NHI Announces Fourth Quarter 2025 Results ACCESS Newswire
26-Feb-2026 MD Clarity Named to G2's 2026 Best Software Awards, Ranking in G2's Top 50 Across All Healthcare Software Categories ACCESS Newswire
26-Feb-2026 Dosell Awarded Framework Agreement in Sweden's First National Procurement of Medication Dispensing Systems ACCESS Newswire
26-Feb-2026 IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research ACCESS Newswire
26-Feb-2026 CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness ACCESS Newswire
26-Feb-2026 Stemtech Corporation Launches New Market Channel Biosciences Ecommerce ACCESS Newswire
26-Feb-2026 Black Book Research Releases "France: State of Acute Care EHR and Digital Health 2026" ACCESS Newswire
26-Feb-2026 IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson's Disease ACCESS Newswire
26-Feb-2026 AlzeCure Publishes its Year-End Report for January - December 2025 ACCESS Newswire
26-Feb-2026 Vicore Pharma to Present at Upcoming Investor Conferences ACCESS Newswire
26-Feb-2026 BioInvent International AB: Year-End Report January 1 - December 31, 2025 ACCESS Newswire
26-Feb-2026 Invitation to Presentation of BioInvent's Year-End Report 2025 ACCESS Newswire